Project description
A tailored approach to dermatology and aesthetic medicine
Skin pathologies like wounds, scars and tumours pose significant public health challenges, with melanoma leading in frequency. Yet, assessing skin biomechanical properties remains elusive, hindering personalised medicine and product development in various fields like aesthetic surgery. In this context, the ERC-funded AssesSkin project will build on the BoneImplant project’s findings with the aim to create a decision support system for skin assessment, using impact-based measurements for a non-invasive, cost-effective device. With a multidisciplinary team, including engineers, a dermatologist and a plastic surgeon, AssesSkin targets regulatory clearance and explores commercial avenues, including potential collaborations with start-up ImpacTell. This innovation promises transformative impacts in dermatology, plastic surgery and aesthetic medicine, heralding a new era of tailored treatments and products.
Objective
Skin pathologies including wounds, scars and tumors represent important public health issues. (e.g. melanoma is the first cancer in terms of increasing frequency). Moreover, skin firmness is an essential property aimed by cosmetic products. However, skin assessment methods remain based on empirical considerations and it is still difficult to determine the skin biomechanical properties, which prevents developing a personalized medicine approach. Such medical device is needed by the physicians to adapt the therapeutic strategy and by the cosmetic manufacturers to develop and validate their product, and to propose the optimal product in a customer-specific manner.
AssesSkin is based on results obtained in the ERC CoG project BoneImplant and aims at developing and validating a medical device consisting in a decision support-system allowing to assess the skin biomechanical properties. The objectives of AssesSkin are i) to achieve a minimum viable product that will be validated in vitro and in vivo, and ii) to investigate its commercial potential and design an exploitation strategy via spin-off creation or licensing. We will explore the possibility to license the technology to ImpacTell, an already existing spin-off of the same laboratory. The originality is to use an impact-based measurement method, which allows to obtain a non-invasive, cheap and easy to use medical device.
Regulatory issues will be at the heart of the development and we will work in order to clear the regulatory pathway of the future medical device. The team is constituted by members with complementary skills (engineers, a business developer, a dermatologist and a plastic surgeon).
AssesSkin will allow the promotion of innovative solution and services in dermatology, plastic surgery and in the cosmetic industry. The long-term vision is for the technology to become a reference in these fields. Strong impacts are associated to AssesSkin, in particular for patients, physicians and cosmetic manufacturers.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine surgery
- medical and health sciences clinical medicine dermatology
- medical and health sciences clinical medicine oncology skin cancer melanoma
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.1 - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2023-POC
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75794 PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.